Choice of the comparator for signal generation in pharmacovigilance databases:: Impact on detection thresholds

被引：0
|
作者：
Pariente, A. [1 ,2 ,3 ]
Didailler, M. [3 ]
Avillach, P. [3 ]
Miremont-Salame, G. [1 ]
Fourrier-Reglat, A. [1 ,3 ]
Haramburu, F. [1 ,3 ]
Moore, N. [1 ,2 ,3 ]
机构：
[1] INSERM, U657, Bordeaux, France
[2] Univ Bordeaux 2, Dept Pharmacol, F-33076 Bordeaux, France
[3] CHU Bordeaux, Dept Pharmacol, Bordeaux, France
来源：
DRUG SAFETY | 2007年 / 30卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：924 / 924
页数：1
相关论文
共 50 条
  • [11] Data Mining on Electronic Health Record Databases for Signal Detection in Pharmacovigilance: Which Events To Monitor?
    Trifiro, Gianluca
    Pariente, Antoine
    Coloma, Preciosa M.
    Kors, Jan A.
    Polimeni, Giovanni
    Miremont-Salame, Ghada
    Catania, Maria Antonietta
    Salvo, Francesco
    David, Anaelle
    Moore, Nicholas
    Caputi, Achille P.
    Sturkenboom, Miriam
    Molokhia, Mariam
    Cox, Julia Hippisley
    Diaz, Carlos
    van der Lei, Johan
    Fourrier-Reglat, Annie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S212 - S212
  • [12] Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Trifiro, Gianluca
    Pariente, Antoine
    Coloma, Preciosa M.
    Kors, Jan A.
    Polimeni, Giovanni
    Miremont-Salame, Ghada
    Catania, Maria Antonietta
    Salvo, Francesco
    David, Anaelle
    Moore, Nicholas
    Caputi, Achille Patrizio
    Sturkenboom, Miriam
    Molokhia, Mariam
    Hippisley-Cox, Julia
    Acedo, Carlos Diaz
    van der Lei, Johan
    Fourrier-Reglat, Annie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (12) : 1176 - 1184
  • [13] The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies
    Hauben, Manfred
    Hung, Eric
    Wood, Jennifer
    Soitkar, Amit
    Reshef, Daniel
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (05) : 145 - 156
  • [14] Impact of the 'French Levothyrox crisis' on signal detection in the WHO pharmacovigilance database
    Khouri, C.
    Revol, B.
    Lepelley, M.
    Mallaret, M.
    Cracowski, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 20 - 20
  • [15] Erratum to: Principles of signal detection in pharmacovigilance
    R H B Meyboom
    A C G Egberts
    I R Edwards
    Drug Safety, 1997, 17 : 118 - 118
  • [16] Changepoint Analysis in Pharmacovigilance Signal Detection
    Scholl, Joep
    van Hunsel, Florence
    van Puijenbroek, Eugene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 534 - 535
  • [17] Signal generation in pharmacovigilance - More than numbers
    Shakir, SAW
    DRUG SAFETY, 2005, 28 (10) : 967 - 967
  • [18] Choice of comparison and impact of stratification in vaccine pharmacovigilance
    Jakobsson, Malin
    Noren, Niklas G.
    Hopstadius, Johan
    Bate, Andrew
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S182 - S182
  • [19] Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
    Caster, Ola
    Aoki, Yasunori
    Gattepaille, Lucie M.
    Grundmark, Birgitta
    DRUG SAFETY, 2020, 43 (05) : 479 - 487
  • [20] Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
    Ola Caster
    Yasunori Aoki
    Lucie M. Gattepaille
    Birgitta Grundmark
    Drug Safety, 2020, 43 : 479 - 487
12345